Healthcare Triangle is trading 5.72% down now at $0.52 as Nasdaq’s October 1 delisting determination over failure to meet the $1 minimum bid-price rule weighs on shares.
- The company faces an October 8 appeal deadline; without an appeal, trading could be suspended October 12.
- Shares closed down 8.39% on October 6 and 16.29% on October 5.
- Broader markets are also lower on October 7, adding pressure, though the Nasdaq threat is the clearer company-specific concern.